+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NEULANDLAB

Neuland Laboratories Share Price

 

 

Neuland Laboratories live price: ₹19506. It opened at ₹19,701 vs previous close ₹19,542; intraday high/low: ₹19,730/₹19,353. The 50 & 200 DMA stand at ₹17,250.70/₹15,320.94.

Neuland Laboratories Performance

  • Today's Low
  • ₹19,353
  • Today's High
  • ₹19,730
  • 52 Week Low
  • ₹11,500
  • 52 Week High
  • ₹20,089
  • Open Price₹19,701
  • Previous Close₹19,542
  • Volume24,863
  • 50 DMA₹17,250.70
  • 100 DMA₹16,226.28
  • 200 DMA₹15,320.94

Neuland Laboratories Chart

Investment Returns

  • Over 1 Month + 13.49%
  • Over 3 Month + 32.49%
  • Over 6 Month + 32.03%
  • Over 1 Year + 62.98%

Smart Investing Starts Here Start SIP with Neuland Laboratories for Steady Growth!

Invest Now

Neuland Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 68.8
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 25,026
  • P/B Ratio
  • 13.4
  • Average True Range
  • 607.1
  • EPS
  • 283.71
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 579.91
  • RSI
  • 77.14
  • MFI
  • 85.8

Latest Stock News Updates

Mukul Agrawal portfolio: Neuland zooms 75% from March low; hits record high

Share price of Neuland Laboratories rallied 6 per cent to hit a record high of 20,072 on the BSE in Thursday's intra-day, after a gap of eight months.

Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4

Neuland Laboratories shares saw a significant jump following a strong Q4 performance. The company reported a massive increase in profit and revenue year-on-year. This robust financial result was driven by strong business momentum across key segments. The company is also investing in future growth through strategic initiatives.

Neuland Laboratories Results Earnings Call for Q4FY26 & Full Year

Conference Call with Neuland Laboratories Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Neuland Laboratories Financials

Neuland Laboratories Technicals

EMA & SMA

Current Price
₹19,506.00
-36 (-0.18%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹18,359.30
  • 50 Day
  • ₹17,250.70
  • 100 Day
  • ₹16,226.30
  • 200 Day
  • ₹15,320.90

Resistance and Support

19529.67 Pivot Speed
  • R3 20,083.33
  • R2 19,906.67
  • R1 19,706.33
  • S1 19,329.33
  • S2 19,152.67
  • S3 18,952.33

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Neuland Laboratories is a leading pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs) and custom manufacturing solutions. It serves global pharmaceutical companies with high-quality APIs for critical therapeutic areas, including cardiovascular and central nervous system.

Neuland Laboratories has an operating revenue of Rs. 2,022.99 Cr. on a trailing 12-month basis. An annual revenue growth of 37% is outstanding, Pre-tax margin of 24% is great, ROE of 19% is exceptional. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 22% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 6% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 88 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 47 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Neuland Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-12 Audited Results & Final Dividend
2026-02-09 Quarterly Results
2025-11-07 Quarterly Results
2025-07-31 Quarterly Results
2025-05-15 Audited Results & Final Dividend
Date Purpose Remarks
2026-07-24 FINAL Rs.34.00 per share(340%)Final Dividend
2025-07-18 FINAL Rs.12.00 per share(120%)Final Dividend
2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend
View Neuland Laboratories Dividend History Arrow

Neuland Laboratories Shareholding Pattern

32.63%
11.35%
1.3%
20.46%
0%
23.85%
10.41%

Neuland Laboratories FAQs

Neuland Laboratories share price is ₹19,506 As on 10 July, 2026 | 20:16

The Market Cap of Neuland Laboratories is ₹25026 Cr As on 10 July, 2026 | 20:16

The P/E ratio of Neuland Laboratories is 68.8 As on 10 July, 2026 | 20:16

The PB ratio of Neuland Laboratories is 13.4 As on 10 July, 2026 | 20:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23